Lungs News and Research

RSS

Mutations in the targets of designer drugs critically influence their effectiveness

Two designer cancer drugs differed dramatically in a laboratory test comparing their ability to shut down a mutant, overactive growth signal in lung cancer cells, reports a team headed by scientists at the Dana-Farber Cancer Institute.

18 Aug 2005

How much people eat is in direct relation to how much they are served

If you binged for two weeks while on vacation and gained 5 pounds, would you be biologically primed to eat less to compensate and shake off the excess weight? No, suggests a new Cornell University study.

15 Aug 2005

Lung cancer cure possible with early screening

Recent reports in the media of the deaths of well known people from lung cancer and the surprising news that Dana Reeve, the non-smoking wife of the late Christopher Reeve has the disease, has re-ignited concerns about the so-called 'silent killer', lung cancer.

15 Aug 2005

Body's own defense mechanism causes some of the most serious asthma symptoms

McGill University Health Centre (MUHC) scientists have discovered that our body's own defense mechanism causes some of the most serious asthma symptoms.

13 Aug 2005

Roflumilast could become a new therapeutic strategy for patients with chronic obstructive pulmonary disease

An anti-inflammatory drug called roflumilast could become a new therapeutic strategy for patients with chronic obstructive pulmonary disease (COPD), conclude the results of a randomised trial in this week’s issue of The Lancet.

11 Aug 2005

Protein that protects the body from tissue damage also increases the risk of tumors

You win some, you lose some. A protein that protects the body from tissue damage also increases the risk of tumors, according to a study conducted at Washington University School of Medicine in St. Louis. Moderate reduction of the protein level protects against tumor formation but increases susceptibility to tissue injury.

11 Aug 2005

Introgen announces additional broad patent in China

Introgen Therapeutics has announced that a patent with broad claims directed to combination therapy with the p53 gene and conventional chemotherapy or radiation was issued in China.

11 Aug 2005

FDA approval sought for Pfizer's new cancer drug

Drug company Pfizer has announced it has submitted a New Drug Application (NDA) for its cancer drug Sutent, to the U.S. Food and Drug Administration (FDA).

11 Aug 2005

Expert warns of spread of Rocky Mountain Spotted Fever

An expert on infectious diseases at Johns Hopkins University School of Medicine, is warning that humans can inadvertently help spread infectious organisms beyond traditional state boundaries.

11 Aug 2005

Researchers identify protein called EMP-1 that is present in the tumors of patients who fail to respond to treatment with gefitinib

By the time the human genome was mapped, cancer researchers had already begun investigating the proteins that were encoded by these newly identified genes.

9 Aug 2005

New theory as to why some people die during sleep

According to scientists the reason why some people stop breathing fatally in their sleep, is because a cumulative loss of cells in the area of the brain that controls breathing triggers a condition called central sleep apnoea.

9 Aug 2005

Factors inhibiting the brain's natural self-healing process identified

Factors that inhibit the brain's natural self-healing process and that may offer new insights into how to prevent brain damage in premature babies have been identified by a team of researchers supported in part by the March of Dimes.

7 Aug 2005

Nighttime dying linked to sleep apnea from brain cell loss

Aim to grow old and die peacefully in your sleep? Be careful what you wish for. A new UCLA study suggests that some people die in their sleep because they stop breathing due to a cumulative loss of cells in the brain's breathing command-post. The online edition of Nature Neuroscience reports the findings.

7 Aug 2005

Relationship between allergies and mold spores in lawns

"Have you ever driven down the road and seen someone mowing the lawn wearing a mask? This is an example of the relationship between allergies and mold spores in lawns. Dr. Phil Colbaugh, research plant pathologist at the Texas Agricultural Experiment Station in Dallas, cites a common image seen in Texas throughout the warm weather months.

2 Aug 2005

Strategic analyses of European In-Vitro cancer diagnostics market - Cancer research yields promising results

Every year, nearly one in four Europeans - a total of almost one million people - dies from cancer, giving Europe the dubious distinction of having amongst the highest cancer-related mortality rates in the world. Even as cancer remains a difficult disease to diagnose, often resulting in either poor diagnosis or misdiagnosis, the number of new cancer cases is set to double by 2020.

2 Aug 2005

Tobacco industry is continuing its targeted marketing to teens via candy-flavored cigarettes

Advertising and promotion for these products uses hip-hop imagery, attractive women, and other imagery to appeal to youth in similar ways that Joe Camel did a decade ago.

2 Aug 2005

Discovery that oxidative stress from pollen is as important as antigen exposure could lead to new therapies

For a person with allergies or asthma, breathing in pollen can be a very bad thing. Within minutes of inhalation by someone sensitive to their effects, these tiny particles can trigger severe inflammation of the respiratory passages, producing uncontrollable sneezing, coughing, or extreme shortness of breath -- symptoms agonizingly familiar to those who suffer from allergy and asthma attacks.

1 Aug 2005

Inhibitors of cellular enzymes could be developed for SARS treatment

Researchers from the University of Pennsylvania School of Medicine have found that inhibitors of an enzyme called cathepsin L prevent the SARS (severe acute respiratory syndrome) virus from entering target cells. SARS is caused by an emergent coronavirus. There is no effective treatment at this time.

1 Aug 2005

Heparinase I is not a suitable replacement for protamine

The results of an international clinical trial led by Duke University Medical Center researchers has shown that a new drug is not a suitable replacement for protamine, a drug that has been used for more than 40 years after coronary artery bypass surgery to return thinned blood to its normal state.

1 Aug 2005

Defect in the mechanics of motors that build tiny cellular hairs is the basis of Bardet-Biedl syndrome

A defect in the mechanics of motors that build tiny cellular hairs is the basis of a serious genetic disorder, according to researchers at UC Davis and Simon Fraser University, Canada.

1 Aug 2005

Lungs News and Research

Mutations in the targets of designer drugs critically influence their effectiveness

How much people eat is in direct relation to how much they are served

Lung cancer cure possible with early screening

Body's own defense mechanism causes some of the most serious asthma symptoms

Roflumilast could become a new therapeutic strategy for patients with chronic obstructive pulmonary disease

Protein that protects the body from tissue damage also increases the risk of tumors

Introgen announces additional broad patent in China

FDA approval sought for Pfizer's new cancer drug

Expert warns of spread of Rocky Mountain Spotted Fever

Researchers identify protein called EMP-1 that is present in the tumors of patients who fail to respond to treatment with gefitinib

New theory as to why some people die during sleep

Factors inhibiting the brain's natural self-healing process identified

Nighttime dying linked to sleep apnea from brain cell loss

Relationship between allergies and mold spores in lawns

Strategic analyses of European In-Vitro cancer diagnostics market - Cancer research yields promising results

Tobacco industry is continuing its targeted marketing to teens via candy-flavored cigarettes

Discovery that oxidative stress from pollen is as important as antigen exposure could lead to new therapies

Inhibitors of cellular enzymes could be developed for SARS treatment

Heparinase I is not a suitable replacement for protamine

Defect in the mechanics of motors that build tiny cellular hairs is the basis of Bardet-Biedl syndrome

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News